(Q43240250)

17 November 2017

title

Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions (English)

1 reference

17 November 2017

1 reference

2

1 reference

17 November 2017

Erica L Horinek

1

1 reference

17 November 2017

Douglas N Fish

series ordinal

3

1 reference

17 November 2017

Robert MacLaren

series ordinal

4

1 reference

17 November 2017

language of work or name

English

0 references

publication date

17 November 2009

1 reference

Annals of Pharmacotherapy

17 November 2017

published in

1 reference

17 November 2017

volume

43

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

1964-1971

1 reference

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

17 November 2017

cites work

1 reference

Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults

21 January 2018

1 reference

Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.

21 January 2018

1 reference

Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion

21 January 2018

1 reference

Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation

21 January 2018

1 reference

A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients

21 January 2018

1 reference

Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study.

21 January 2018

1 reference

APACHE II: a severity of disease classification system

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M313

1 reference

17 November 2017

1 reference